Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Elevated Prostate Specific Antigen”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT00685633
What this trial is testing

Bicalutamide With or Without Enzastaurin in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT01162135
What this trial is testing

Digoxin for Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT03541850
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery

Who this might be right for
PSA Level Greater Than 0.03PSA ProgressionStage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7+2 more
Jonsson Comprehensive Cancer Center 92
Testing effectiveness (Phase 2)UnknownNCT00045123
What this trial is testing

R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence

Who this might be right for
Prostate Cancer
Myrexis Inc.
Large-scale testing (Phase 3)UnknownNCT00567580
What this trial is testing

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,792
Not applicableStudy completedNCT02155998
What this trial is testing

Non-Interventional Study PREVENT

Who this might be right for
Postoperative or Postradiation Adjuvant Androgen Deprivation Therapy in Locally Advanced Prostate Cancer (High and Very High Risk) Patients
AstraZeneca 200
Large-scale testing (Phase 3)Ended earlyNCT00514917
What this trial is testing

Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Participants With a Rising Prostate Specific Antigen (PSA)

Who this might be right for
Prostatic Neoplasms
Sanofi 413
Not applicableStudy completedNCT00242060
What this trial is testing

Functional and Morphologic MRI in the Detection of Prostate Cancer in Patients With Prior Negative Biopsy

Who this might be right for
Elevated PSAProstate Cancer
University Health Network, Toronto
Not applicableStudy completedNCT01763944
What this trial is testing

Carbohydrate Restriction and Prostate Cancer Growth

Who this might be right for
Prostate Cancer
Duke University 83
Large-scale testing (Phase 3)Active Not RecruitingNCT05794906
What this trial is testing

Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies

Who this might be right for
Biochemically Recurrent Prostate Cancer
Bayer 985
Testing effectiveness (Phase 2)Active Not RecruitingNCT02312557
What this trial is testing

Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide

Who this might be right for
Castration-Resistant Prostate CarcinomaHormone-Resistant Prostate CancerPSA Progression+2 more
OHSU Knight Cancer Institute 58
Large-scale testing (Phase 3)Looking for participantsNCT07052214
What this trial is testing

PSMA PET Combined With MRI for the Detection of PCa

Who this might be right for
PCAProstate CancerProstatic Neoplasm+6 more
Telix Pharmaceuticals (Innovations) Pty Limited 338
Testing effectiveness (Phase 2)Active Not RecruitingNCT01786265
What this trial is testing

Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaRecurrent Prostate Carcinoma
M.D. Anderson Cancer Center 310
Not applicableNot Yet RecruitingNCT06669273
What this trial is testing

Oncological Prognosis of Prostate Lesions by Chemical Exchange Saturation Transfer Magnetic Resonance Imaging (CEST-MRI)

Who this might be right for
Suspected Prostate Cancer (increased PSA Level)
University Hospital, Clermont-Ferrand 70
Early research (Phase 1)Study completedNCT00148928
What this trial is testing

Safety & Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSA

Who this might be right for
Neoplasms, Prostate
GlaxoSmithKline 25
Not applicableEnded earlyNCT04745871
What this trial is testing

Diagnostic Performance of PSMA PET/CT for Pre-operative Lymph Node Assessment in Intermediate and High-risk Non-metastasic Prostate Cancer (PREOP-PSMA ).

Who this might be right for
Prostate Cancer
University Hospital, Brest 112
Testing effectiveness (Phase 2)Study completedNCT00678054
What this trial is testing

Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) for Patients With Rising Prostate-Specific Antigen (PSA)

Who this might be right for
Prostate Cancer
University of California, San Francisco 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04915508
What this trial is testing

Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy

Who this might be right for
Prostate AdenocarcinomaStage IIIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage IIIC Prostate Cancer AJCC v8+3 more
Jonsson Comprehensive Cancer Center 165
Not applicableStudy completedNCT03881709
What this trial is testing

The Efficacy of Decision Support E-book for Prostate Biopsy Decision Making

Who this might be right for
Prostate-Specific Antigen
National Taipei University of Nursing and Health Sciences 110
Early research (Phase 1)Study completedNCT00178113
What this trial is testing

A Pilot Study of Lycopene Supplementation in Prostatic Intraepithelial Neoplasia

Who this might be right for
Prostatic Intraepithelial Neoplasia
University of Pittsburgh 80
Next Page